semaglutide for obesity showed tirzepatide 10 mg or 15 mg produced significantly greater reductions in body weight and waist circumference over 72 weeks compared to semaglutide 1.7 mg or 2.4 mg, with both drugs having mostly mild-to-moderate gastrointestinal side effects during dose escalation
Revisiting a Place Many Players Never Forgot For longtime Maplers, Ludibrium was more than just another region
Agenda Co-chairs Dr Luz de Regil Director, Department of Nutrition and Food Safety, WHO and Dr Kirsten Bibbins Domingo Editor-in-Chief, JAMA Moderator Dr Gaya Manori Gamhewage, Director, Department of Communication, WHO Welcoming Dr Luz De Regil Director NFS, WHO and Dr Kirsten Bibbins-Domingo, Editor-in-Chief, JAMA Presentation: WHO guideline on the use of glucagon-like peptide-1 (GLP-1) therapies for the treatment of obesity in adults Dr Francesca Celletti, Senior Advisor Obesity, Department of Nutrition and Food Safety, WHO and Dr
Mesenchymal stem cell-derived exosomes for treatment of autism spectrum disorder
78,86,180 Neurotrauma boosts neurogenesis and migration of neuroblasts into the perilesional penumbra, where they arguably contribute to the neuronal circuitry repair
Researchers may study this compound in controlled experimental settings focused on: Metabolic pathway analysis Peptide receptor interaction studies Growth hormone fragment research Cellular signaling investigations Obesity and lipid metabolism models Endocrine-related peptide studies These applications are intended exclusively for scientific and laboratory research purposes
